Research Library
Evidence-based research guides, scientific articles, and educational resources on BPC-157, Semaglutide, Retatrutide, Weight Loss, Healing and more. Updated regularly for laboratory and independent research.
FDA Peptide Ban Reversal 2026: What Researchers Must Know Now
FDA peptide ban reversal could reopen 503B bulk list to cosmetic peptides by Q2 2026, restoring GHK-Cu, Argireline, and Matrixyl for dermatology research.
Antimicrobial Peptides in Cancer Research 2026: Mechanisms & Trials
Antimicrobial peptides cancer research shows LL-37 and defensins trigger immunogenic cell death, inhibit angiogenesis, and enhance checkpoint blockade in 2026 pre-clinical models.
FDA Approves Lilly's Foundayo: Research Implications
FDA approval of Lilly's Foundayo redefines GLP-1 research standards. This guide details molecular specs, receptor pharmacology, and procurement of research-grade analogs.
FDA Peptide Restriction Lift: 2026
FDA peptide restriction lift expected in 2026 will reclassify several research peptides from Category II to Category I, expanding laboratory access to high-purity compounds for in-vitro and animal studies.
FDA Peptide Ban List 2025: What Research Labs Need to Know
FDA peptide ban list 2025 explained: which compounds are restricted, why compounding rules changed, and how research labs can maintain compliant procurement.
Anti-Aging Peptide Research: Compounds Behind the Trend
Anti-aging peptide research examines bioactive sequences that modulate collagen synthesis, cellular senescence, and longevity pathways. Discover the mechanisms driving this field in 2026.